They have developed a H5N1 vaccine but it’s not yet approved. Maybe this could be a catalyst for this stock? Idk
ChatGPT: Yes, Novavax has developed an H5N1 vaccine. Novavax worked on a candidate vaccine for the H5N1 avian influenza virus, which was part of its broader pandemic preparedness efforts. Their H5N1 vaccine was based on their proprietary nanoparticle technology and has shown promise in preclinical and clinical trials.
Novavax has developed an H5N1 vaccine, but it has not received widespread approval or distribution. Its development was primarily aimed at preparing for potential future pandemics rather than addressing a current public health threat.